UBS Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6M | Buy |
1,028,889
+607,057
| +144% | +$14.5M | ﹤0.01% | 1691 |
|
|
2025
Q1 | $10.5M | Sell |
421,832
-952,957
| -69% | -$23.7M | ﹤0.01% | 2318 |
|
|
2024
Q4 | $25.9M | Buy |
1,374,789
+1,184,034
| +621% | +$22.3M | ﹤0.01% | 1565 |
|
|
2024
Q3 | $2.87M | Buy |
190,755
+125,097
| +191% | +$1.88M | ﹤0.01% | 2746 |
|
|
2024
Q2 | $1.88M | Sell |
65,658
-99,803
| -60% | -$2.86M | ﹤0.01% | 2903 |
|
|
2024
Q1 | $4.83M | Buy |
165,461
+39,875
| +32% | +$1.17M | ﹤0.01% | 2223 |
|
|
2023
Q4 | $4.24M | Buy |
125,586
+69,513
| +124% | +$2.35M | ﹤0.01% | 2154 |
|
|
2023
Q3 | $1.72M | Buy |
56,073
+31,699
| +130% | +$973K | ﹤0.01% | 2667 |
|
|
2023
Q2 | $977K | Sell |
24,374
-5,177
| -18% | -$207K | ﹤0.01% | 3333 |
|
|
2023
Q1 | $1.21M | Buy |
29,551
+2,145
| +8% | +$87.5K | ﹤0.01% | 3032 |
|
|
2022
Q4 | $1.06M | Buy |
27,406
+6,763
| +33% | +$261K | ﹤0.01% | 3094 |
|
|
2022
Q3 | $1.1M | Sell |
20,643
-1,642
| -7% | -$87.3K | ﹤0.01% | 2784 |
|
|
2022
Q2 | $1.3M | Buy |
22,285
+764
| +4% | +$44.5K | ﹤0.01% | 2693 |
|
|
2022
Q1 | $1.64M | Sell |
21,521
-2,027
| -9% | -$155K | ﹤0.01% | 2822 |
|
|
2021
Q4 | $1.42M | Sell |
23,548
-1,533
| -6% | -$92.2K | ﹤0.01% | 3166 |
|
|
2021
Q3 | $1.41M | Sell |
25,081
-10,422
| -29% | -$584K | ﹤0.01% | 3005 |
|
|
2021
Q2 | $2.15M | Sell |
35,503
-12,500
| -26% | -$758K | ﹤0.01% | 2678 |
|
|
2021
Q1 | $3.37M | Sell |
48,003
-13,283
| -22% | -$931K | ﹤0.01% | 2297 |
|
|
2020
Q4 | $3.67M | Buy |
61,286
+36,384
| +146% | +$2.18M | ﹤0.01% | 2114 |
|
|
2020
Q3 | $1.5M | Sell |
24,902
-13,516
| -35% | -$813K | ﹤0.01% | 2649 |
|
|
2020
Q2 | $2.02M | Sell |
38,418
-8,765
| -19% | -$460K | ﹤0.01% | 2280 |
|
|
2020
Q1 | $1.58M | Sell |
47,183
-27,529
| -37% | -$923K | ﹤0.01% | 2343 |
|
|
2019
Q4 | $3.39M | Buy |
74,712
+56,874
| +319% | +$2.58M | ﹤0.01% | 2317 |
|
|
2019
Q3 | $679K | Sell |
17,838
-900
| -5% | -$34.3K | ﹤0.01% | 3483 |
|
|
2019
Q2 | $815K | Buy |
18,738
+2,250
| +14% | +$97.9K | ﹤0.01% | 3189 |
|
|
2019
Q1 | $628K | Buy |
16,488
+9,264
| +128% | +$353K | ﹤0.01% | 3223 |
|
|
2018
Q4 | $311K | Sell |
7,224
-1,149
| -14% | -$49.5K | ﹤0.01% | 3802 |
|
|
2018
Q3 | $411K | Buy |
8,373
+621
| +8% | +$30.5K | ﹤0.01% | 3775 |
|
|
2018
Q2 | $248K | Sell |
7,752
-17,384
| -69% | -$556K | ﹤0.01% | 3965 |
|
|
2018
Q1 | $783K | Sell |
25,136
-1,100
| -4% | -$34.3K | ﹤0.01% | 3202 |
|
|
2017
Q4 | $1.2M | Buy |
26,236
+2,310
| +10% | +$105K | ﹤0.01% | 2892 |
|
|
2017
Q3 | $899K | Buy |
23,926
+6,117
| +34% | +$230K | ﹤0.01% | 3072 |
|
|
2017
Q2 | $849K | Buy |
17,809
+3,336
| +23% | +$159K | ﹤0.01% | 3037 |
|
|
2017
Q1 | $660K | Buy |
14,473
+7,117
| +97% | +$325K | ﹤0.01% | 3111 |
|
|
2016
Q4 | $238K | Buy |
7,356
+2,392
| +48% | +$77.4K | ﹤0.01% | 3823 |
|
|
2016
Q3 | $170K | Sell |
4,964
-408
| -8% | -$14K | ﹤0.01% | 3838 |
|
|
2016
Q2 | $181K | Sell |
5,372
-416
| -7% | -$14K | ﹤0.01% | 3806 |
|
|
2016
Q1 | $307K | Sell |
5,788
-501
| -8% | -$26.6K | ﹤0.01% | 3482 |
|
|
2015
Q4 | $483K | Buy |
6,289
+349
| +6% | +$26.8K | ﹤0.01% | 3173 |
|
|
2015
Q3 | $244K | Buy |
5,940
+5,096
| +604% | +$209K | ﹤0.01% | 3570 |
|
|
2015
Q2 | $59K | Sell |
844
-12,353
| -94% | -$864K | ﹤0.01% | 4662 |
|
|
2015
Q1 | $1.17M | Sell |
13,197
-5,970
| -31% | -$530K | ﹤0.01% | 2698 |
|
|
2014
Q4 | $1.7M | Buy |
+19,167
| New | +$1.7M | ﹤0.01% | 2362 |
|